Reply
J Allergy Clin Immunol
.
2020 Nov;146(5):1214-1215.
doi: 10.1016/j.jaci.2020.07.028.
Epub 2020 Aug 14.
Authors
Daniel J Jackson
1
,
William W Busse
2
,
Alkis Togias
3
,
James E Gern
2
,
Mathew C Altman
4
Affiliations
1
University of Wisconsin School of Medicine and Public Health, Madison, Wis. Electronic address: djj@medicine.wisc.edu.
2
University of Wisconsin School of Medicine and Public Health, Madison, Wis.
3
The National Institute of Allergy and Infectious Diseases, Bethesda, Md.
4
Department of Medicine, University of Washington, Seattle, Wash; Benaroya Research Institute, Systems Immunology Division, Seattle, Wash.
PMID:
32828589
PMCID:
PMC7427546
DOI:
10.1016/j.jaci.2020.07.028
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
Comment
MeSH terms
Asthma*
COVID-19*
Humans
Hypersensitivity*
Peptidyl-Dipeptidase A
SARS-CoV-2
Substances
Peptidyl-Dipeptidase A
Grants and funding
UM1 AI109565/AI/NIAID NIH HHS/United States
UM1 AI114271/AI/NIAID NIH HHS/United States